Blend review · Cognition & mood

Semax / Selank

A catalogue blend name combining two individually studied peptides. The selected publications describe the named components, not an established combined formulation or a demonstrated advantage of mixing them.

By HeartPep · Reviewed · 4 selected source records

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

At a glance

No direct clinical trial of this catalogue combination was identified in the bounded search. Three component-only clinical/imaging references and one identity-only analytical paper provide background; none validates the supplied blend.

Identity & scope

The exact catalogue alias is Semax/Selank. The product's own labelled quantities and format remain separate specifications; component names alone do not verify blend composition, compatibility or stability.

Catalogue labels covered: Semax/Selank.

What the research shows

  • Human studies have examined Semax-related imaging changes and Selank-related symptom ratings independently.
  • The study whose title names both peptides allocated participants to separate Semax, Selank or placebo groups. It cannot demonstrate synergy or combined-product effectiveness.

Critical interpretation

A two-name title is not a combination trial

A paper mentioning both peptides can still test them in separate groups. Such a design cannot establish an interaction between them. The relevant next experiment would compare a characterized mixture with each component and a suitable control, using the same predefined outcome. [1]

Identity evidence answers a separate question

Analytical identification is essential background, but even a correctly identified ingredient does not demonstrate a useful mixture. The forensic paper illustrates laboratory identification in other preparations; it neither certifies this catalogue blend nor supplies a combined-product trial. Ratio, stability and interactions remain separate open questions. [4]

Limitations & uncertainties

  • Effects observed for one ingredient cannot be added together to predict a mixture's effects.
  • The cited studies do not establish blend interactions, a combined safety profile or equivalence of a nasal product to another preparation.
  • A combined name does not resolve independent identity, content, impurity, formulation or shelf-life questions for a supplied batch.

Open research questions

  • Has a precisely characterized combined formulation been tested against its individual components and placebo?
  • Does combining the peptides change exposure, stability, interactions or measured outcomes?

Selected papers & source records

Download bibliography
Human studyComponent evidenceAbstract / record checked

1. Functional Connectomic Approach to Studying Selank and Semax Effects (opens in a new tab)

Panikratova YR et al. (2020). Dokl Biol Sci. DOI: 10.1134/S001249662001007X (opens in a new tab) · PMID 32342318

Design & population
Acute resting-state fMRI study in 52 healthy participants receiving Semax, Selank or placebo separately.
What the study found
The authors reported amygdala-to-temporal-cortex connectivity differences.
Limits on interpretation
Surrogate imaging endpoints; neither clinical effectiveness nor combined-blend effects established.
Human studyComponent evidenceAbstract / record checked

2. Effects of Semax on the Default Mode Network of the Brain (opens in a new tab)

Lebedeva IS et al. (2018). Bull Exp Biol Med. DOI: 10.1007/s10517-018-4234-3 (opens in a new tab) · PMID 30225715

Design & population
Resting-state fMRI experiment in 24 healthy adults, with Semax and placebo groups.
What the study found
The Semax group showed a larger rostral default-mode-network subcomponent.
Limits on interpretation
Small, acute imaging study; no established improvement in practical cognition.
Human studyComponent evidenceAbstract / record checked

3. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia (opens in a new tab)

Zozulia AA et al. (2008). Zh Nevrol Psikhiatr Im S S Korsakova. · PMID 18454096

Design & population
Clinical comparison of Selank and medazepam in 62 patients; PubMed indexes a randomized trial.
What the study found
The abstract reports similar anxiety-related effects between groups.
Limits on interpretation
Small active-comparator study; Russian full text not reviewed and no placebo arm described in the abstract.
Chemical analysisIdentity / technical contextAbstract / record checked

4. The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind (opens in a new tab)

Vanhee C et al. (2020). Drug Test Anal. DOI: 10.1002/dta.2717 (opens in a new tab) · PMID 31667971

Design & population
Analytical investigation of suspicious preparations and development of a mass-spectrometric screening method for research peptides.
What the study found
The investigators identified preparations containing the named peptides and developed analytical screening methods.
Limits on interpretation
These were other preparations, not HeartPep batches. Identification does not establish a combined formulation's effects, safety or stability.

Search & review scope

Searched for combination/blend trials and checked whether original reports administered the components together or separately. Initial selection on 8 November was substantively extended on 9 November, with clinical searches, accessible full-text consultation and bounded publication-notice checks.. Checked 9 November 2026.

Direct blend evidence sought; individually administered component studies retained for background.

A bounded search cannot prove that no combination research exists. The complete retrieved PubMed record for PMID32342318 showed no linked retraction/erratum section; some other record fetches were incomplete. No paper here establishes the supplied blend.

Recorded search terms
  • site:pubmed.ncbi.nlm.nih.gov "Semax" "Selank" combination blend trial
  • site:pubmed.ncbi.nlm.nih.gov/32342318/
  • site:pubmed.ncbi.nlm.nih.gov/30225715/
  • site:pubmed.ncbi.nlm.nih.gov/18454096/
  • site:pubmed.ncbi.nlm.nih.gov/31667971/

Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.

Cite this review

HeartPep. Semax / Selank: blend review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/uk/research/library/semax-selank.

HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

← All reviews and reference notes